Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease that is associated with joint pain and stiffness. Biologics represent some of the most effective treatments for RA, but previous guidance from the National Institute for Health and Care Excellence (NICE) has limited their use to...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C., Askari, Ayman, Choy, Ernest, Ehrenstein, Michael R., Else, Sara, Nisar, Muhammad K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925364/
https://www.ncbi.nlm.nih.gov/pubmed/36782189
http://dx.doi.org/10.1186/s12916-023-02746-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925364/
https://www.ncbi.nlm.nih.gov/pubmed/36782189
http://dx.doi.org/10.1186/s12916-023-02746-5

Ejemplares similares